Acumen Research and Consulting
-
Mineralys in Radnor Sees Stock Price Explode After Hypertension Drug Test
The Radnor biopharmaceutical firm Mineralys Therapeutics saw its stock price hit new heights Monday after a positive late-stage clinical trial showed promise for its new…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
